Assessing Ketorolac (Toradol) at Oocyte Retrieval

Description

To determine if a nonsteroidal anti-inflammatory drug (NSAID), Ketorolac (Toradol), can improve pain control and decrease narcotic use after undergoing egg retrieval.

Conditions

Infertility, Infertility, Female, Oocyte Retrieval, Postoperative Pain, Embryo Transfer

Talk to us

Study Overview

On this page

Study Details

Study overview

To determine if a nonsteroidal anti-inflammatory drug (NSAID), Ketorolac (Toradol), can improve pain control and decrease narcotic use after undergoing egg retrieval.

A Randomized Blinded Placebo Controlled Trial Assessing Ketorolac (Toradol) at Oocyte Retrieval

Assessing Ketorolac (Toradol) at Oocyte Retrieval

Condition
Infertility
Intervention / Treatment

-

Contacts and Locations

Rockville

Shady Grove Fertility Reproductive Science Center, Rockville, Maryland, United States, 20850

Fairfax

Shady Grove Fertility Reproductive Science Center, Fairfax, Virginia, United States, 22031

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Signed informed consent
  • 2. Females over 18 years of age who are scheduled to undergo oocyte retrieval
  • 3. Patients must be able to read and understand written English or have an appropriate certified medical translator available.
  • 4. Standard eligibility criteria to undergo IVF and embryo transfer at Shady Grove
  • 1. Known allergy to ketorolac
  • 2. Those with known medical conditions precluding them from ketorolac use (active peptic ulcer disease, recent or history of hemorrhage or perforation, known renal or hepatic insufficiency, suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, bleeding disorders, recent myocardial infarction, or stroke.)
  • 3. BMI ≥ 40 kg/m2
  • 4. History of substance abuse
  • 5. Chronic opioid use
  • 6. Transabdominal oocyte retrieval

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Shady Grove Fertility Reproductive Science Center,

Kathleen Devine, MD, PRINCIPAL_INVESTIGATOR, Shady Grove Fertility Reproductive Science Center

Study Record Dates

2025-01